{
    "LDLR": {
        "fullName": "",
        "chromosome": "",
        "summary": "",
        "variants": [
            {
                "variant code": "LDLR 0017",
                "c.": "c.-187_-185del",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "promoter region",
                "Variant type": "5'UTR",
                "Allele type": "Null",
                "ClinVar ID": 438314,
                "ClinGen Allele Registry ID": "CA645509248",
                "FH VCEP evidence codes": "PM2, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HepG2), luciferase assays",
                "Result of functional study1": "8% reporter gene expression",
                "Authors1": "Peeters et al., 1998",
                "PMID1": 9610768
            },
            {
                "variant code": "LDLR 0020",
                "c.": "c.-156C>T",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "promoter region",
                "Variant type": "5'UTR",
                "Allele type": "Defective",
                "ClinVar ID": 250942,
                "ClinGen Allele Registry ID": "CA10584696",
                "FH VCEP evidence codes": "PM2, PP4, PS4_Supporting, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-03-20",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HepG2), luciferase assays (High-throughput screening, deep mutational scanning category)",
                "Result of functional study1": "considered repressing variant (luciferase activity 15-17% of wild-type)",
                "Authors1": "Kircher et al., 2019",
                "PMID1": 31395865
            },
            {
                "variant code": "LDLR 0023",
                "c.": "c.-153C>T",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "promoter region",
                "Variant type": "5'UTR",
                "Allele type": "Defective",
                "ClinVar ID": 250944,
                "ClinGen Allele Registry ID": "CA10584698",
                "FH VCEP evidence codes": "PM2, PS3_Supporting, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2022-10-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HepG2), luciferase assays (High-throughput screening, deep mutational scanning category)",
                "Result of functional study1": "considered repressing variant (luciferase activity 38-42% of wild-type)",
                "Authors1": "Kircher et al., 2019",
                "PMID1": 31395865
            },
            {
                "variant code": "LDLR 0033",
                "c.": "c.-138T>C",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "promoter region",
                "Variant type": "5'UTR",
                "Allele type": "Defective",
                "ClinVar ID": 250952,
                "ClinGen Allele Registry ID": "CA10584706",
                "FH VCEP evidence codes": "PM2, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2022-10-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (COS), luciferase assays",
                "Result of functional study1": "40-50% reporter gene expression",
                "Authors1": "Sun et al., 1995",
                "PMID1": 8589690
            },
            {
                "variant code": "LDLR 0040",
                "c.": "c.-120C>T",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS - conflicting",
                "Curated by FH VCEP?": "yes",
                "Location": "promoter region",
                "Variant type": "5'UTR",
                "Allele type": "Null",
                "ClinVar ID": 226299,
                "ClinGen Allele Registry ID": "CA10576265",
                "FH VCEP evidence codes": "PM2, PP1, PP4, PS3_Supporting, PS4_Supporting, BP2",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HepG2), luciferase assays",
                "Result of functional study1": "3% reporter gene transcription",
                "Authors1": "Francova et al., 2004",
                "PMID1": 15303010
            },
            {
                "variant code": "LDLR 0041",
                "c.": "c.-101T>C",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "promoter region",
                "Variant type": "5'UTR",
                "Allele type": "ND",
                "ClinVar ID": 250957,
                "ClinGen Allele Registry ID": "CA10584711",
                "FH VCEP evidence codes": "PM2, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-02-10",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (Huh7), luciferase assays",
                "Result of functional study1": "64% reporter gene expression",
                "Authors1": "Khamis et al., 2015",
                "PMID1": 25248394
            },
            {
                "variant code": "LDLR 0059",
                "c.": "c.-187-?_190+?del",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "promoter to intron 2",
                "Variant type": "large indel (CNV)",
                "Allele type": "ND",
                "ClinVar ID": 1703194,
                "ClinGen Allele Registry ID": null,
                "FH VCEP evidence codes": "PVS1, PS4, PM2, PP1_Moderate, PP4, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-03-25",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients's fibroblasts, 125I-LDL assays",
                "Result of functional study1": "45% LDLR activity",
                "Authors1": "Garuti et al., 1996",
                "PMID1": 8678915
            },
            {
                "variant code": "LDLR 0069",
                "c.": "c.1A>C",
                "p.": "p.Met1Leu",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 1",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 250966,
                "ClinGen Allele Registry ID": "CA10584718",
                "FH VCEP evidence codes": "PS3, PM2, PVS1_Moderate, PP1_Moderate, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-04-22",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS and luciferase assays",
                "Result of functional study1": "60% cell surface LDLR, 59% binding and 66% uptake. 5% luciferase construct activity",
                "Authors1": "Graça et al., 2021",
                "PMID1": 34572405
            },
            {
                "variant code": "LDLR 0089",
                "c.": "c.44T>C",
                "p.": "p.Leu15Pro",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 1",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 250981,
                "ClinGen Allele Registry ID": "CA10584732",
                "FH VCEP evidence codes": "PM2, PS3_moderate, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), CLSM assays",
                "Result of functional study1": "LDLR retained in ER, no LDL-LDLR binding",
                "Authors1": "Pavlouskova et al., 2016",
                "PMID1": 27175606
            },
            {
                "variant code": "LDLR 0126",
                "c.": "c.81C>G",
                "p.": "p.Cys27Trp",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 2",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 226304,
                "ClinGen Allele Registry ID": "CA041664",
                "FH VCEP evidence codes": "PS4, PM1, PM2, PS3_Moderate, PP1, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-05-06",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "15-30% LDLR activity",
                "Authors1": "Hobbs et al., 1992",
                "PMID1": 1301956
            },
            {
                "variant code": "LDLR 0161",
                "c.": "c.139G>A",
                "p.": "p.Asp47Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 2",
                "Variant type": "missense",
                "Allele type": "Normal",
                "ClinVar ID": 251034,
                "ClinGen Allele Registry ID": "CA041918",
                "FH VCEP evidence codes": "BS3, PM2, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO-ldlA7), FACS and western blot assays",
                "Result of functional study1": "Normal (95%) expression, binding and uptake",
                "Authors1": "Benito-Vicente et al., 2018b",
                "PMID1": 30413722
            },
            {
                "variant code": "LDLR 0175",
                "c.": "c.185C>T",
                "p.": "p.Thr62Met",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 2",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 161273,
                "ClinGen Allele Registry ID": "CA023598",
                "FH VCEP evidence codes": "PP1",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-23",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO-ldlA7), FACS and western blot assays",
                "Result of functional study1": "Normal expression (97%), binding (84%) and uptake (99%)",
                "Authors1": "Benito-Vicente et al., 2018b",
                "PMID1": 30413722
            },
            {
                "variant code": "LDLR 2464",
                "c.": "c.226G>C",
                "p.": "p.Gly76Arg",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 1331775,
                "ClinGen Allele Registry ID": "CA042515",
                "FH VCEP evidence codes": "PS3_Moderate, PP3",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HEK-293), WB and CLSM assays",
                "Result of functional study1": "63% uptake",
                "Authors1": "Hu et al., 2021",
                "PMID1": 34970301
            },
            {
                "variant code": "LDLR 0221",
                "c.": "c.226G>T",
                "p.": "p.Gly76Trp",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS - conflicting",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "missense",
                "Allele type": "Normal",
                "ClinVar ID": 251081,
                "ClinGen Allele Registry ID": "CA10584797",
                "FH VCEP evidence codes": "BS3, PM2, PP1_Moderate, PP4, PP3, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS and WB assays",
                "Result of functional study1": "normal cell surface LDLR (102%), LDL-LDLR binding (90%) and internalization (95%)",
                "Authors1": "Benito-Vicente et al., 2015",
                "PMID1": 25741862
            },
            {
                "variant code": "LDLR 0254",
                "c.": "c.268G>A",
                "p.": "p.Asp90Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 251105,
                "ClinGen Allele Registry ID": "CA042604",
                "FH VCEP evidence codes": "PM5_Strong, PM2, PS3_Moderate, PS4_Moderate, PP1_Moderate, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (COS-7), FACS assays",
                "Result of functional study1": "55% LDLR cell surface LDLR and activity",
                "Authors1": "Chang et al., 2003",
                "PMID1": 12837857
            },
            {
                "variant code": "LDLR 0260",
                "c.": "c.274C>G",
                "p.": "p.Gln92Glu",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 251108,
                "ClinGen Allele Registry ID": "CA042636",
                "FH VCEP evidence codes": "PM2, PP4, BP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2022-10-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "Normal cell surface LDLR (98%), LDL-LDLR binding (97%) and uptake (79%)",
                "Authors1": "Alves et al., 2021",
                "PMID1": 34167030
            },
            {
                "variant code": "LDLR 0271",
                "c.": "c.292G>A",
                "p.": "p.Gly98Ser",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "missense",
                "Allele type": "Normal",
                "ClinVar ID": 251118,
                "ClinGen Allele Registry ID": "CA042749",
                "FH VCEP evidence codes": "BS3",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2024-02-23",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO-ldlA7) alone and with , WB, FACS and CLSM",
                "Result of functional study1": "Normal expression (95%), binding (98%) and uptake (110%)",
                "Authors1": "Jiang et al., 2017",
                "PMID1": 28645073
            },
            {
                "variant code": "LDLR 0272",
                "c.": "c.292G>C",
                "p.": "p.Gly98Arg",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 251119,
                "ClinGen Allele Registry ID": "CA10584830",
                "FH VCEP evidence codes": "PM2, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2024-02-23",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "84% cell surface LDLR, 87% LDL-LDLR binding and 82% internalization",
                "Authors1": "Graça et al., 2022",
                "PMID1": 35568682
            },
            {
                "variant code": "LDLR 0273",
                "c.": "c.296C>G",
                "p.": "p.Ser99*",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "nonsense",
                "Allele type": "Defective",
                "ClinVar ID": 161269,
                "ClinGen Allele Registry ID": "CA023685",
                "FH VCEP evidence codes": "PVS1, PS4, PM2, PP4, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Epstein-Barr virus transformed lymphocytes from htz patients, FACS and RNA assays",
                "Result of functional study1": "~60% gene expression, LDL-LDLR uptake and protein at cell surface",
                "Authors1": "Holla et al., 2009b",
                "PMID1": 19148831
            },
            {
                "variant code": "LDLR 0280",
                "c.": "c.301G>A",
                "p.": "p.Glu101Lys",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 3",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 161266,
                "ClinGen Allele Registry ID": "CA023687",
                "FH VCEP evidence codes": "PS4, PP1_Strong, PM2, PM3, PS3_Moderate, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-12-13",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": " Hmz patient fibroblast, 125I-LDL assays",
                "Result of functional study1": "15-30% LDLR activity",
                "Authors1": "Hobbs et al., 1992",
                "PMID1": 1301956
            },
            {
                "variant code": "LDLR 0299",
                "c.": "c.313+2T>C",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 3",
                "Variant type": "splicing",
                "Allele type": "Defective",
                "ClinVar ID": 189296,
                "ClinGen Allele Registry ID": "CA023690",
                "FH VCEP evidence codes": "PS4, PVS1_strong, PM2, PM3, PS3_moderate, PP1_moderate, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-02-14",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "10% LDLR activity",
                "Authors1": "Kolansky et al., 2008",
                "PMID1": 19026292
            },
            {
                "variant code": "LDLR 0302",
                "c.": "c.313+6T>C",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 3",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 251138,
                "ClinGen Allele Registry ID": "CA10584845",
                "FH VCEP evidence codes": "PM2, PS3_Supporting, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-26",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' lymphocytes, RNA assays",
                "Result of functional study1": "skipping of exon 3 (p.Leu64_Pro105delinsSer)",
                "Authors1": "Bourbon et al., 2009",
                "PMID1": 19411563
            },
            {
                "variant code": "LDLR 0337",
                "c.": "c.344G>A",
                "p.": "p.Arg115His",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 4",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 225402,
                "ClinGen Allele Registry ID": "CA043240",
                "FH VCEP evidence codes": "PS3",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (COS-7), FACS assays",
                "Result of functional study1": "65% LDLR expression and activity",
                "Authors1": "Chang et al., 2003",
                "PMID1": 12837857
            },
            {
                "variant code": "LDLR 1932",
                "c.": "c.440C>T",
                "p.": "p.Thr147Ile",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 4",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 251223,
                "ClinGen Allele Registry ID": "CA10584919",
                "FH VCEP evidence codes": "PM1, PM2, PP3, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' Epstein-Barr virus transformed lymphocytes, FACS assays",
                "Result of functional study1": "55-70% LDLR activity",
                "Authors1": "Romano et al., 2011",
                "PMID1": 21865347
            },
            {
                "variant code": "LDLR 0496",
                "c.": "c.542C>G",
                "p.": "p.Pro181Arg",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 4",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 183089,
                "ClinGen Allele Registry ID": "CA023717",
                "FH VCEP evidence codes": "PM1, PM2, PS3_Moderate, PS4_Moderate, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2024-02-23",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (COS-7) cells",
                "Result of functional study1": "Mature/precursor LDLR forms ratio ~60%",
                "Authors1": "Garcia-Garcia et al., 2011",
                "PMID1": 21868016
            },
            {
                "variant code": "LDLR 0574",
                "c.": "c.654_656del",
                "p.": "p.Gly219del",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 4",
                "Variant type": "in frame indel",
                "Allele type": "Null",
                "ClinVar ID": 226329,
                "ClinGen Allele Registry ID": "CA023734",
                "FH VCEP evidence codes": "PS4, PP1_Strong, PM2, PM4, PS3_moderate, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-06-02",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "<2% LDLR activity",
                "Authors1": "Hobbs et al., 1992",
                "PMID1": 1301956
            },
            {
                "variant code": "LDLR 0598",
                "c.": "c.665G>T",
                "p.": "p.Cys222Phe",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 4",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 251362,
                "ClinGen Allele Registry ID": "CA10585053",
                "FH VCEP evidence codes": "PM1, PM2, PS3_Moderate, PP3, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HEK-293), FACS and CLSM assays",
                "Result of functional study1": "30 % cell surface LDLR and internalization",
                "Authors1": "Wang et al., 2014",
                "PMID1": 24671153
            },
            {
                "variant code": "LDLR 0634",
                "c.": "c.681C>G",
                "p.": "p.Asp227Glu",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 4",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 3690,
                "ClinGen Allele Registry ID": "CA023747",
                "FH VCEP evidence codes": "PS4, PP1_Strong, PM1, PM2, PS3_Moderate, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2022-04-29",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "5-15% LDLR activity",
                "Authors1": "Hobbs et al., 1992",
                "PMID1": 1301956
            },
            {
                "variant code": "LDLR 0715",
                "c.": "c.796G>A",
                "p.": "p.Asp266Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 5",
                "Variant type": "missense",
                "Allele type": "Null",
                "ClinVar ID": 226334,
                "ClinGen Allele Registry ID": "CA10576288",
                "FH VCEP evidence codes": "PS4, PM5_Strong, PM2, PS3_Moderate, PP1, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-05-04",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "<2% LDLR activity",
                "Authors1": "Slimane et al., 2002",
                "PMID1": 12414836
            },
            {
                "variant code": "LDLR 0719",
                "c.": "c.798T>A",
                "p.": "p.Asp266Glu",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 5",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 161287,
                "ClinGen Allele Registry ID": "CA023765",
                "FH VCEP evidence codes": "PS4, PM5_Strong, PP1_Strong, PM2, PS3_Moderate, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "15-30% LDLR activity",
                "Authors1": "Hobbs et al., 1992",
                "PMID1": 1301956
            },
            {
                "variant code": "LDLR 0724",
                "c.": "c.806G>A",
                "p.": "p.Gly269Asp",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely benign",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 5",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 161279,
                "ClinGen Allele Registry ID": "CA023767",
                "FH VCEP evidence codes": "BS2, BP2, PP1_Moderate",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' lymphocytes, FACS assays",
                "Result of functional study1": "normal LDLR at cell surface (90%), LDL-LDLR binding (90%) and LDL uptake (100%)",
                "Authors1": "Etxebarria et al., 2012",
                "PMID1": 21990180
            },
            {
                "variant code": "LDLR 0741",
                "c.": "c.818-2A>G",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 5",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 251471,
                "ClinGen Allele Registry ID": "CA10585149",
                "FH VCEP evidence codes": "PVS1, PM2, PP1_Moderate, PP4, PS4_Supporting, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-12-13",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' lymphocytes, RNA assays",
                "Result of functional study1": "Retention of 10 nt of intron5 (p.Val273Glyfs*31)",
                "Authors1": "Medeiros et al., 2010",
                "PMID1": 20828696
            },
            {
                "variant code": "LDLR 0757",
                "c.": "c.846C>A",
                "p.": "p.Phe282Leu",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 6",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183098,
                "ClinGen Allele Registry ID": "CA023778",
                "FH VCEP evidence codes": "PM2, PP3, PP4, PS3_Supporting, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "In vitro microscopy assays in HeLa cells",
                "Result of functional study1": "LDLR activity decreased compared to WT - considered as disruptive ",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 0761",
                "c.": "c.853C>T",
                "p.": "p.His285Tyr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 6",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183099,
                "ClinGen Allele Registry ID": "CA023780",
                "FH VCEP evidence codes": "PM2, BP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-03-24",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "in vitro microscopy assays in heterologous (HeLa) cells",
                "Result of functional study1": "LDLR activity similar to WT - considered as non-disruptive",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 0785",
                "c.": "c.890A>C",
                "p.": "p.Asn297Thr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 6",
                "Variant type": "missense",
                "Allele type": "Normal",
                "ClinVar ID": 441197,
                "ClinGen Allele Registry ID": "CA404080954",
                "FH VCEP evidence codes": "BS3, PM2, PP3",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-02-14",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO-ldlA7), WB, FACS and CLSM",
                "Result of functional study1": "Normal expression (91%), binding (97%) and uptake (100%)",
                "Authors1": "Jiang et al., 2017",
                "PMID1": 28645073
            },
            {
                "variant code": "LDLR 0789",
                "c.": "c.895G>A",
                "p.": "p.Ala299Thr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 6",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 251507,
                "ClinGen Allele Registry ID": "CA10585179",
                "FH VCEP evidence codes": "PM2, PP4, PS4_Supporting, PS3_supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-02-10",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz Patient lymphocytes, FACS assays",
                "Result of functional study1": "normal cell surface, 50% LDL-LDLR uptake and binding",
                "Authors1": "Etxebarria et al., 2012",
                "PMID1": 21990180
            },
            {
                "variant code": "LDLR 0792",
                "c.": "c.898A>G",
                "p.": "p.Arg300Gly",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 6",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 251510,
                "ClinGen Allele Registry ID": "CA030068",
                "FH VCEP evidence codes": "PS3, PM2",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2022-10-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "normal cell surface LDLR (95%), 55% LDL-LDLR binding and uptake",
                "Authors1": "Etxebarria et al., 2015b",
                "PMID1": 25545329
            },
            {
                "variant code": "LDLR 0799",
                "c.": "c.910G>A",
                "p.": "p.Asp304Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 6",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 3692,
                "ClinGen Allele Registry ID": "CA023792",
                "FH VCEP evidence codes": "PS4, PP1_Strong, PM2, PM3, PS3_Moderate, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-12-17",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "5-15% LDLR activity",
                "Authors1": "Hobbs et al., 1992",
                "PMID1": 1301956
            },
            {
                "variant code": "LDLR 0862",
                "c.": "c.941-12G>A",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 6",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 251552,
                "ClinGen Allele Registry ID": "CA10585217",
                "FH VCEP evidence codes": "PM2, PP1, PP4, PS3_Supporting, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-03-30",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "patient's monocytes, RNA assays",
                "Result of functional study1": "abnormal splicing of intron 6",
                "Authors1": "Marduel et al., 2010",
                "PMID1": 20809525
            },
            {
                "variant code": "LDLR 0886",
                "c.": "c.974G>A",
                "p.": "p.Cys325Tyr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 7",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 251580,
                "ClinGen Allele Registry ID": "CA10585234",
                "FH VCEP evidence codes": "PM1, PM2, PS4_Moderate, PP3, PP4, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-02-09",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' Epstein-Barr virus transformed lymphocytes, FACS assays",
                "Result of functional study1": "50-60% LDLR activity",
                "Authors1": "Romano et al., 2011",
                "PMID1": 21865347
            },
            {
                "variant code": "LDLR 0887",
                "c.": "c.977C>G",
                "p.": "p.Ser326Cys",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 7",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 251581,
                "ClinGen Allele Registry ID": "CA10585235",
                "FH VCEP evidence codes": "PS3, PP1_Strong, PM2, PP3, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-04-05",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "Normal cell surface LDLR (90%), 50% binding and 48% uptake",
                "Authors1": "Galicia-Garcia et al., 2020",
                "PMID1": 32015373
            },
            {
                "variant code": "LDLR 0896",
                "c.": "c.1003G>A",
                "p.": "p.Gly335Ser",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 7",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183105,
                "ClinGen Allele Registry ID": "CA023402",
                "FH VCEP evidence codes": "PM2, PP3, PP4, PS4_Supporting, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "30-40% LDLR activity",
                "Authors1": "Hobbs et al., 1992",
                "PMID1": 1301956
            },
            {
                "variant code": "LDLR 2451",
                "c.": "c.1003G>T",
                "p.": "p.Gly335Cys",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 7",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 1395739,
                "ClinGen Allele Registry ID": "CA404082719",
                "FH VCEP evidence codes": "PM2, PS3_Moderate, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HEK293), Western blot and Dil-LDL (just uptake) assays",
                "Result of functional study1": "less mature LDLR detected, 43% uptake",
                "Authors1": "Hu et al. 2021",
                "PMID1": 34970301
            },
            {
                "variant code": "LDLR 2457",
                "c.": "c.1049G>A",
                "p.": "p.Arg350Gln",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS - conflicting",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 7",
                "Variant type": "missense",
                "Allele type": "Normal",
                "ClinVar ID": 689349,
                "ClinGen Allele Registry ID": "CA305299648",
                "FH VCEP evidence codes": "PM2, PP4, BS3, BP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "100% LDLR expression, binding and uptake",
                "Authors1": "Rodríguez‐Jiménez et al., 2019",
                "PMID1": 31106925
            },
            {
                "variant code": "LDLR 1022",
                "c.": "c.1133A>C",
                "p.": "p.Gln378Pro",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 8",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183108,
                "ClinGen Allele Registry ID": "CA023422",
                "FH VCEP evidence codes": "PM2, PM3, PS4_Moderate, PP1_Moderate, PP3, PP4 ",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-05-06",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "Normal cell surface LDLR (96%), binding (101%) and uptake (80%)",
                "Authors1": "Galicia-Garcia et al., 2020",
                "PMID1": 32015373
            },
            {
                "variant code": "LDLR 1053",
                "c.": "c.1186+5G>A",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 8",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 251706,
                "ClinGen Allele Registry ID": "CA10585344",
                "FH VCEP evidence codes": "PM2, PS3_Moderate, PS4_Moderate, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-08",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' lymphocytes, FACS, CLSM and RNA assays",
                "Result of functional study1": "50-60% cell surface LDLR, LDL-LDLR binding and internalization; retention of part of intron 8 (p.G396fs*26)",
                "Authors1": "Etxebarria et al., 2012",
                "PMID1": 21990180
            },
            {
                "variant code": "LDLR 1090",
                "c.": "c.1211C>T",
                "p.": "p.Thr404Ile",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 9",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 251736,
                "ClinGen Allele Registry ID": "CA10585360",
                "FH VCEP evidence codes": "PM2, PM3, PP3, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2022-10-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HEK 393), WB, FACS assays",
                "Result of functional study1": "Normal cell surface LDLR (95%); 70% LDL-LDLR binding and uptake",
                "Authors1": "Wang et al., 2009",
                "PMID1": 19073363
            },
            {
                "variant code": "LDLR 1094",
                "c.": "c.1216C>T",
                "p.": "p.Arg406Trp",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 9",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 226351,
                "ClinGen Allele Registry ID": "CA033073",
                "FH VCEP evidence codes": "PS3, PS4, PP1_Strong, PM2, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-04-22",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS and WB assays",
                "Result of functional study1": "60-65% LDLR cell surface, LDL-LDLR binding and internalization; reduced mature protein",
                "Authors1": "Benito-Vicente et al., 2015",
                "PMID1": 25741862
            },
            {
                "variant code": "LDLR 1106",
                "c.": "c.1238C>T",
                "p.": "p.Thr413Met",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 9",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 161276,
                "ClinGen Allele Registry ID": "CA023439",
                "FH VCEP evidence codes": "PM2, PS4_Moderate, PP1, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-09",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "Normal cell surface LDLR (100%), binding (80%) and uptake (90%)",
                "Authors1": "Galicia-Garcia et al., 2020",
                "PMID1": 32015373
            },
            {
                "variant code": "LDLR 1141",
                "c.": "c.1301C>G",
                "p.": "p.Thr434Arg",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 9",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 251774,
                "ClinGen Allele Registry ID": "CA10585393",
                "FH VCEP evidence codes": "PS4, PP1_Strong, PM2, PM3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2022-10-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (COS7), ELISA and WB assay",
                "Result of functional study1": "normal LDLR expression",
                "Authors1": "Garcia-Garcia et al., 2011",
                "PMID1": 21868016
            },
            {
                "variant code": "LDLR 1151",
                "c.": "c.1322T>C",
                "p.": "p.Ile441Thr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 9",
                "Variant type": "missense",
                "Allele type": "Null",
                "ClinVar ID": 251783,
                "ClinGen Allele Registry ID": "CA10585400",
                "FH VCEP evidence codes": "PS3, PP1_Strong, PM2, PS4_Moderate, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-09",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS and WB assays",
                "Result of functional study1": "7% cell surface LDLR, 5% LDL-LDLR binding, 10% LDL-LDLR internalization; no mature protein detected",
                "Authors1": "Benito-Vicente et al., 2015",
                "PMID1": 25741862
            },
            {
                "variant code": "LDLR 1180",
                "c.": "c.1359-31_1359-23delinsCGGCT",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 9",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 251805,
                "ClinGen Allele Registry ID": "CA10585420",
                "FH VCEP evidence codes": "PM2, PP4, PS3_supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-03-20",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patient's Epstein-Barr virus transformed lymphoblasts, RNA assays; Heterologous cells (COS), RNA assays",
                "Result of functional study1": "Retention of intron 9 (p.Ser453Argfs*2)",
                "Authors1": "Webb et al., 1996b",
                "PMID1": 8872473
            },
            {
                "variant code": "LDLR 1184",
                "c.": "c.1359-5C>G",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 9",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 251808,
                "ClinGen Allele Registry ID": "CA10585422",
                "FH VCEP evidence codes": "PM2, PP1_Moderate,PP4, PS3_supporting, PS4_supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-27",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' lymphocytes, RNA assays",
                "Result of functional study1": "Retention of intron 9 (p.Ser453Argfs*2)",
                "Authors1": "Bourbon et al., 2009",
                "PMID1": 19411563
            },
            {
                "variant code": "LDLR 1187",
                "c.": "c.1359-1G>A",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 9",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 162499,
                "ClinGen Allele Registry ID": "CA023463",
                "FH VCEP evidence codes": "PVS1, PS4, PP1_Strong, PM2, PP4, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' Epstein Barr virus transformed lymphocytes, RNA assays",
                "Result of functional study1": "skipping of the first 7 nts from exon 10 in 23% of mRNAs (p.Thr454Leufs*51)",
                "Authors1": "Holla et al., 2009",
                "PMID1": 19208450
            },
            {
                "variant code": "LDLR 1199",
                "c.": "c.1381G>T",
                "p.": "p.Gly461Cys",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 10",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183113,
                "ClinGen Allele Registry ID": "CA023475",
                "FH VCEP evidence codes": "PP1_Strong, PM2, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2024-02-23",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "in vitro microscopy assays in heterologous (HeLa) cells",
                "Result of functional study1": "LDLR activity similar to WT - considered as non-disruptive",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 1975",
                "c.": "c.1393T>A",
                "p.": "p.Tyr465Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 10",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183114,
                "ClinGen Allele Registry ID": "CA023482",
                "FH VCEP evidence codes": "PM2, PP3",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "in vitro microscopy assays in heterologous (HeLa) cells",
                "Result of functional study1": "LDLR activity similar to WT - considered as non-disruptive",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 2094",
                "c.": "c.1402G>A",
                "p.": "p.Val468Ile",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 10",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183115,
                "ClinGen Allele Registry ID": "CA023485",
                "FH VCEP evidence codes": "PM2, PP4, BP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-29",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "in vitro microscopy assays in heterologous (HeLa) cells, just uptake",
                "Result of functional study1": "77% LDL uptake",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 1357",
                "c.": "c.1618G>A",
                "p.": "p.Ala540Thr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 11",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 226363,
                "ClinGen Allele Registry ID": "CA035437",
                "FH VCEP evidence codes": "PS4, PP1_Strong, PM2, PM3, PP3, PP4, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' fibroblasts, immunoblot and 125I-LDL assays",
                "Result of functional study1": "cell surface LDLR 40-50% LDLR",
                "Authors1": "Sun et al., 1997",
                "PMID1": 9409298
            },
            {
                "variant code": "LDLR 1441",
                "c.": "c.1729T>G",
                "p.": "p.Trp577Gly",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 12",
                "Variant type": "missense",
                "Allele type": "Null",
                "ClinVar ID": 252000,
                "ClinGen Allele Registry ID": "CA10585585",
                "FH VCEP evidence codes": "PS3, PM2, PP1_Moderate, PP3, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-04-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "10-15% LDL-LDLR binding; 5% LDL-LDLR uptake; 5% cell surface LDLR",
                "Authors1": "Etxebarria et al., 2015",
                "PMID1": 25378237
            },
            {
                "variant code": "LDLR 1946",
                "c.": "c.1739C>T",
                "p.": "p.Ser580Phe",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 12",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 438325,
                "ClinGen Allele Registry ID": "CA305301758",
                "FH VCEP evidence codes": "PM2, PP1, PP3, PP4, PS3_supporting, PS4_supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-11-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' Epstein-Barr virus transformed lymphocytes, FACS assays",
                "Result of functional study1": "64% LDLR activity",
                "Authors1": "Romano et al., 2011",
                "PMID1": 21865347
            },
            {
                "variant code": "LDLR 1458",
                "c.": "c.1747C>G",
                "p.": "p.His583Asp",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 12",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183124,
                "ClinGen Allele Registry ID": "CA023564",
                "FH VCEP evidence codes": "PM2, PM5, PP3, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-11-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "study on HeLa-Kyoto cells, LDLR-GFP construct, WB and CLSM assays",
                "Result of functional study1": "most of mutant LDLR is in ER, LDLR activity decreased compared to WT - considered as disruptive",
                "Authors1": "Thormaehlen et al. 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 1459",
                "c.": "c.1748A>G",
                "p.": "p.His583Arg",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 12",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 252012,
                "ClinGen Allele Registry ID": "CA10585595",
                "FH VCEP evidence codes": "PM2, PM5, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-11-07",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), WB and FACS",
                "Result of functional study1": "77% expression and 80% internalisation",
                "Authors1": "Dušková et al. 2020",
                "PMID1": 32695144
            },
            {
                "variant code": "LDLR 2262",
                "c.": "c.1765G>C",
                "p.": "p.Asp589His",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 12",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183125,
                "ClinGen Allele Registry ID": "CA023571",
                "FH VCEP evidence codes": "PM2, BP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-29",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "in vitro microscopy assays in heterologous (HeLa) cells",
                "Result of functional study1": "LDLR activity similar to WT - considered as non-disruptive",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 1484",
                "c.": "c.1784G>A",
                "p.": "p.Arg595Gln",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 12",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183126,
                "ClinGen Allele Registry ID": "CA023585",
                "FH VCEP evidence codes": "PS4, PM2, PM3, PM5, PS3_Supporting, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-02-02",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' fibroblasts, 125I-LDL assays",
                "Result of functional study1": "70% LDL-LDLR binding, 54-49% LDL-LDLR uptake and degradation",
                "Authors1": "Vuorio et al., 2001",
                "PMID1": 11585102
            },
            {
                "variant code": "LDLR 1551",
                "c.": "c.1855T>C",
                "p.": "p.Phe619Leu",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 13",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 252083,
                "ClinGen Allele Registry ID": "CA037227",
                "FH VCEP evidence codes": "PM2, PP3, PP4, PS4_Supporting, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-18",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterozygous patients lymphoblasts, immunoblotting, I125-LDL assay",
                "Result of functional study1": "no precursor detectable, degradation of 125I-LDL 63%",
                "Authors1": "Sun et al., 1997",
                "PMID1": 9409298
            },
            {
                "variant code": "LDLR 1590",
                "c.": "c.1907G>T",
                "p.": "p.Gly636Val",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 13",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 438327,
                "ClinGen Allele Registry ID": "CA404092833",
                "FH VCEP evidence codes": "PM2, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-29",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HEK-293), FACS assays, CLSM assays",
                "Result of functional study1": "70% cell surface LDLR and internalization",
                "Authors1": "Wang et al., 2014",
                "PMID1": 24671153
            },
            {
                "variant code": "LDLR 1594",
                "c.": "c.1920C>T",
                "p.": "p.Asn640=",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Benign",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 13",
                "Variant type": "synonymous",
                "Allele type": "ND",
                "ClinVar ID": 237869,
                "ClinGen Allele Registry ID": "CA037448",
                "FH VCEP evidence codes": "BA1, BP4, BP7, BS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-01-27",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' lymphocytes, RNA assays",
                "Result of functional study1": "Normal LDLR transcripts  ",
                "Authors1": "Medeiros et al., 2016",
                "PMID1": 26020417
            },
            {
                "variant code": "LDLR 1608",
                "c.": "c.1951G>A",
                "p.": "p.Asp651Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 13",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183128,
                "ClinGen Allele Registry ID": "CA354422",
                "FH VCEP evidence codes": "PM2, PS4_Moderate, PP1, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-03-20",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "in vitro microscopy assays in heterologous (HeLa) cells",
                "Result of functional study1": "LDLR activity similar to WT - considered as non-disruptive",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 1612",
                "c.": "c.1954A>G",
                "p.": "p.Met652Val",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 13",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 183129,
                "ClinGen Allele Registry ID": "CA023615",
                "FH VCEP evidence codes": "PM2",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-12-23",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "in vitro microscopy assays in heterologous (HeLa) cells",
                "Result of functional study1": "LDLR activity similar to WT - considered as non-disruptive",
                "Authors1": "Thormaehlen et al., 2015",
                "PMID1": 25647241
            },
            {
                "variant code": "LDLR 1617",
                "c.": "c.1960C>T",
                "p.": "p.Leu654Phe",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 13",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 252132,
                "ClinGen Allele Registry ID": "CA10585697",
                "FH VCEP evidence codes": "PM2, PP1, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2024-10-28",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), microscopy assays",
                "Result of functional study1": "79-84% LDLR expression and 89->100% LDLR activity",
                "Authors1": "Graça et al., 2023",
                "PMID1": 37719435
            },
            {
                "variant code": "LDLR 1978",
                "c.": "c.1976C>A",
                "p.": "p.Thr659Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 13",
                "Variant type": "missense",
                "Allele type": "Normal",
                "ClinVar ID": 252141,
                "ClinGen Allele Registry ID": "CA10585704",
                "FH VCEP evidence codes": "BS3, PM2",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2023-03-20",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "Normal cell surface LDLR (96%), binding (103%) and uptake (103%)",
                "Authors1": "Galicia-Garcia et al., 2020",
                "PMID1": 32015373
            },
            {
                "variant code": "LDLR 1654",
                "c.": "c.2000G>A",
                "p.": "p.Cys667Tyr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 14",
                "Variant type": "missense",
                "Allele type": "Null",
                "ClinVar ID": 3689,
                "ClinGen Allele Registry ID": "CA023621",
                "FH VCEP evidence codes": "PM1, PM2, PS3_Moderate, PP3, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-18",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Hmz patients' fibroblasts, immunoprecipitation assays; 125I-LDL assays",
                "Result of functional study1": "precursor protein does not mature; <2% LDLR activity",
                "Authors1": "Leitersdorf et al., 1990",
                "PMID1": 2318961
            },
            {
                "variant code": "LDLR 1721",
                "c.": "c.2098G>A",
                "p.": "p.Asp700Asn",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 14",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 200923,
                "ClinGen Allele Registry ID": "CA023633",
                "FH VCEP evidence codes": "PM2, PS3_moderate, PP4, PS4_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-03-25",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "20% uptake",
                "Authors1": "Larrea-Sebal et al., 2021",
                "PMID1": 34869944
            },
            {
                "variant code": "LDLR 1722",
                "c.": "c.2099A>G",
                "p.": "p.Asp700Gly",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 14",
                "Variant type": "missense",
                "Allele type": "Defective",
                "ClinVar ID": 252220,
                "ClinGen Allele Registry ID": "CA10585773",
                "FH VCEP evidence codes": "PS3, PM2, PP3, PP4, PS4_supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-03-25",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "35% cell surface LDLR, 60% binding and 52% uptake",
                "Authors1": "Galicia-Garcia et al., 2020",
                "PMID1": 32015373
            },
            {
                "variant code": "LDLR 1731",
                "c.": "c.2119G>T",
                "p.": "p.Asp707Tyr",
                "Has functional study?": "yes",
                "FH VCEP Classification": "Likely pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 14",
                "Variant type": "missense",
                "Allele type": "Null",
                "ClinVar ID": 252226,
                "ClinGen Allele Registry ID": "CA10585779",
                "FH VCEP evidence codes": "PS3, PM2, PP3, PP4",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2024-02-23",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (CHO), FACS assays",
                "Result of functional study1": "<2% cell surface LDLR, 2% binding and 6% uptake",
                "Authors1": "Galicia-Garcia et al., 2020",
                "PMID1": 32015373
            },
            {
                "variant code": "LDLR 1741",
                "c.": "c.2140+1G>A",
                "p.": null,
                "Has functional study?": "yes",
                "FH VCEP Classification": "Pathogenic",
                "Curated by FH VCEP?": "yes",
                "Location": "intron 14",
                "Variant type": "splicing",
                "Allele type": "ND",
                "ClinVar ID": 3744,
                "ClinGen Allele Registry ID": "CA023643",
                "FH VCEP evidence codes": "PVS1, PP1_Strong, PM2, PS4_Moderate, PP4, PS3_Supporting",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2021-06-18",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Htz patients' lymphocytes, FACS assays",
                "Result of functional study1": "50% LDLR activity ",
                "Authors1": "Takada et al., 2002",
                "PMID1": 12522687
            },
            {
                "variant code": "LDLR 1827",
                "c.": "c.2374A>T",
                "p.": "p.Ile792Phe",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 16",
                "Variant type": "missense",
                "Allele type": "ND",
                "ClinVar ID": 252294,
                "ClinGen Allele Registry ID": "CA10585833",
                "FH VCEP evidence codes": "PM2, PP3",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1 - ",
                "link": "https://clinicalgenome.org/site/assets/files/6301/clingen_fh_acmg_specifications_v1_1-1.pdf",
                "Date of classification": "2022-08-26",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HepG2), WB and imunoprecipitation assays",
                "Result of functional study1": "Normal cell surface LDLR",
                "Authors1": "Strom et al., 2015",
                "PMID1": 26220972
            },
            {
                "variant code": "LDLR 1878",
                "c.": "c.2441G>A",
                "p.": "p.Arg814Gln",
                "Has functional study?": "yes",
                "FH VCEP Classification": "VUS",
                "Curated by FH VCEP?": "yes",
                "Location": "exon 17",
                "Variant type": "missense",
                "Allele type": "Null",
                "ClinVar ID": 161278,
                "ClinGen Allele Registry ID": "CA023671",
                "FH VCEP evidence codes": "BS1, PS3, PP3",
                "Guideline version": "ClinGen Familial Hypercholesterolemia Expert Panel LDLR Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2",
                "link": "https://cspec.genome.network/cspec/ui/svi/doc/GN013",
                "Date of classification": "2024-08-30",
                "Curated by": "FH VCEP",
                "studied in PerMedFH?": "no",
                "Type of functional study (sample type, assay)1": "Heterologous cells (HepG2 transfected cells with CRISPR/Cas9), FACS, WB, and CLSM assays. ",
                "Result of functional study1": "FACS: ~40% cell surface LDLR, 6% binding, and 7% uptake; WB: altered expression of LDLR in HepG2 cells transfected",
                "Authors1": "Mori et al., 2024",
                "PMID1": 37739193
            }
        ]
    }
}